News

DBT invites comments on Draft document on Genome Edited Organisms: Regulatory Framework and Guidelines for Risk Assessment

In view of the recent developments in the field of Genome Editing Technologies a need was felt to bring out guidelines.

Read More

Jan 13, 2020

By : Team ABLE

DBT announces Third Call under ATGC program

DBT would enable academic researchers to take their fundamental research to next phase via translational research opportunities under Accelerated Translational Grant for Commercialization (ATGC).

Read More

Jan 13, 2020

By : Team ABLE

FDA, USDA, EPA create a joint platform to streamline agricultural biotechnology products’ information

The Unified Website for Biotechnology Regulation describes the federal review process for certain biotechnology products and allows users to submit questions to the three agencies.

Read More

Jan 10, 2020

By : Team ABLE

Bolt Biotherapeutics expands Scientific Advisory Board with appointment of Dr. Priti Hegde

Dr. Hegde completed her post-doctoral fellow at The Institute for Genomic Research, holds a Ph.D. in Biochemical Pharmacology from SUNY Buffalo, and a B. Pharmacy from Mumbai University.

Read More

Jan 10, 2020

By : Team ABLE

University of Dundee researchers are on a new effort to tackle tuberculosis with $3 million grant from the Bill & Melinda Gates Foundation

Professor Paul Wyatt's team in the University's School of Life Sciences will identify new treatment options for TB, under the banner of the `LEADS4TB' program

Read More

Jan 10, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights